Sodium ferrous citrate and 5‐aminolevulinic acid improve type 2 diabetes by maintaining muscle and mitochondrial health
Sodium ferrous citrate and 5‐aminolevulinic acid improve type 2 diabetes by maintaining muscle and mitochondrial health
复制标题
DOI:
10.1002/oby.23705
复制
发表时间:
2023-02
期刊:
影响因子:
6.9
通讯作者:
Naho Kitamura;Shiyang Zhang;Jean-David Morel;Utana Nagano;Tanon Taworntawat;Shotaro Hosoda;Anna Nakamu
中科院分区:
文献类型:
--
作者:
Naho Kitamura;Shiyang Zhang;Jean-David Morel;Utana Nagano;Tanon Taworntawat;Shotaro Hosoda;Anna Nakamu
Improving mitochondrial function is a promising strategy for intervention in type 2 diabetes mellitus. This study investigated the preventive effects of sodium ferrous citrate (SFC) and 5‐aminolevulinic acid phosphate (ALA) on several metabolic dysfunctions associated with obesity because they have been shown to alleviate abnormal glucose metabolism in humans.